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HLA-B27 transgenic (TG) rats develop spontaneous colitis when colonized




 HLA-B27 TG rats
remain disease free. The present study was designed to determine whether or
not HLA-B27 expression on T cells is required for development of colitis after





ients. Athymic nontransgenic (non-TG) and HLA-B27 TG recipients received






 heterozygous donor rats that con-




 recipients receiving either non-TG or TG
MLN cells developed severe colitis and had higher caecal MPO and IL-1β
 
 lev-
els, and their MLN cells produced more IFN-γ
 









ents that remained disease free after receiving either TG or non-TG cells.
Interestingly, proliferating donor TG T cells were detectable one week after




 TG recipients but not after transfer into non-





 TG but not in non-TG rats, suggesting that activation of effector T cells by









Many animal models of experimental colitis support the con-
cept that inflammatory bowel diseases (IBD) occur due to an
overly aggressive immune response to commensal nonpatho-
genic bacteria in a genetically susceptible host [1]. In these
models, the genetically susceptible host develops colitis when
housed under specific pathogen-free (SPF) conditions,
whereas the germ-free state prevents intestinal inflammation.
A well-characterized model of experimental colitis is the
HLA-B27 transgenic (TG) rat model. HLA-B27 TG rats





microglobulin develop spontaneous colitis in SPF conditions





, is able to induce colitis in this
model [4,5]. However, intestinal inflammation does not
occur in germ-free animals [6] or after monoassociation









 in response to caecal bacterial lysates
[7]. Taken together, these results suggest that commensal
luminal bacteria play a crucial role in the induction and per-
petuation of colitis in HLA-B27 TG RATS.




 T cells, are required for
the development of inflammation in HLA-B27 TG rats, as
shown in cell transfer studies using athymic HLA-B27 TG























rats, intestinal inflammation developed [8]. We showed pre-




 T cells stimulated with caecal





 and IL-12 [7]. These findings emphasize the




 cells, in the patho-
genesis of colitis in the HLA-B27 TG model. However, a
requirement for expression of HLA-B27 by the T cells has
not been evaluated.
Our results show that MLN cells from either non-TG or
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non-TG recipient rats. These findings suggest that activation
of T cells by HLA-B27-expressing accessory cells, defined as
non-T cells that either present antigen to T cells or perform
costimulatory functions, is pivotal to the pathogenesis of






We used HLA-B27 TG F344 strain rats of the 33–3 line [2,9]
and their non-TG littermates that were either homozygous or






























 rats are euthymic and have normal T cell
function [8]. Animals were all maintained under SPF housing
conditions at the University of North Carolina, Chapel Hill.
Presence or absence of the HLA-B27 transgene was deter-
mined by PCR using DNA isolated from tail clippings. All
studies were approved by University of North Carolina at













 non-TG and TG rats. After obtaining single
MLN cell suspensions by gentle teasing, the cells were








 unfractionated MLN cells were





 non-TG and TG recipients. After eight
weeks, rats were euthanized. Caecal and colonic tissue and
MLN were collected. Based on histological findings, similar
levels of intestinal inflammation in recipients of different
ages were observed.









rats were labelled with carboxyfluorescein diacetate succin-
imidyl ester (CFSE) (Molecular Probes, Eugene, OR, USA)
to monitor them after transfer, as described previously
[12,13]. After obtaining single MLN cell suspensions by gen-
tle teasing, the cells were washed twice and incubated with








PBS for 15 min at room temperature.
The labelling process was terminated by adding an equal vol-
ume of fetal calf serum. Flow cytometry analyses showed
greater than 99% of MLN cells were labelled with CFSE. The
cells were washed three times, and equal number of cells,

















 non-TG recipients. Rats were euthanized
on day two or seven after injection, and flow cytometry was
performed on recipient MLN and spleen cells, and recipient








Tissues from different sections of the intestinal tract (proxi-
mal, transverse, and distal colon, and caecum) were collected
from each recipient. The tissues were fixed and stained as
previously described [3,14]. Histological scoring (range
from 0 to 4) was based on well-validated criteria and carried
out on blinded samples by one evaluator [3,14].
 
Preparation of caecal bacterial lysates
 
Caecal bacterial lysates were prepared as described previ-
ously [7,15]. Briefly, caecal contents from several non-TG





m) [7]. Sterility was confirmed by aerobic
and anaerobic bacterial culture.
 
Mesenteric lymph node cell cultures
 




 non-TG and TG
recipients, and single cell suspensions were prepared, as
described previously [7]. Unseparated MLN cells were








 cells were stimulated with caecal
bacterial lysate cultured in 96 well flat bottom microplates
(Costar 3595), in 0·2 ml complete medium (RPMI 1640 plus




















g/ml gentamicin) for three days, as described [7]. Cells
were stimulated with concentrations of caecal bacterial lysate
that we found to be optimal for the induction of different


























 non-TG rats were mixed with equivalent
numbers of MLN cells from rnu/rnu TG rats in 0·2 ml com-
plete medium in 96 well flat bottom microplates and incu-









(Amersham Biosciences, Piscataway, NJ, USA) was added. At
the end of the incubation period, the plates were frozen, then





ration was measured using the TopCount NXT Microplate





MLN cell fractions were evaluated by flow cytometry using
the following fluorochrome labelled or unlabelled reagents,
as previously described [7]. For detection of HLA-B27-
expressing cells, we used culture supernatants from the
murine hybridoma, designated ME-1, obtained from ATCC





-chain specific) antibody (Southern Bio-
technology, Birmingham, AL, USA) or APC labelled rat anti-
mouse IgG1 (BD Biosciences Pharmingen, San Diego, CA,
USA). For surface immunoglobulin positive B cells, we used




 L) antibody (Kirkeg-
aard & Perry Laboratories, Gaithersburg, MD, USA). For
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expressing cells we used PE-anti-CD4 monoclonal antibody
(clone W3/25), and FITC anti-CD8 monoclonal antibody





 (clone R73), and FITC anti-rat
CD45RC (clone OX-22) (BD Biosciences Pharmingen),
respectively. Lymphocytes were gated according to forward
and side scatter characteristics and analysed using




Cytokines in cell culture supernatants were measured by
ELISA using unlabelled capture antibodies and biotin-
labelled detection antibodies, followed by horse-radish per-
oxidase labelled Streptavidin [7]. The concentration of each
cytokine was determined by comparison to a standard curve














 antibody (clone DB-1) (Bio-
source International, Camarillo, CA, USA). For IL-10 ELISA
we used unlabelled monoclonal anti-rat IL-10 antibody
(clone A5-7) and biotin-labelled monoclonal anti-rat IL-10





Caecal cytokines were measured as described previously
[14]. Briefly, caecal tissues were homogenized in PBS con-
taining a cocktail of protease inhibitors [16], after which the




 according to the manu-
facturer’s instructions (National Institute for Biological




Homogenized caeca were assayed for MPO activity (units
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Donor and recipient MLN cell populations 
before cell transfer
 















 non-TG or TG rats
were used as donor cells for adoptive transfer. The TG donor
rats had moderate colitis with histology scores of 1·5–2·0 on
a 0–4 scale (data not shown). Non-TG donor MLN cells con-
tained a higher proportion of B cells and a lower proportion
of T cells compared to those from their TG littermates that
developed colitis (Table 1). Also, both the TG and the non-




 cells that express
low levels of CD45RC (Table 1). B cells were the predomi-




 non-TG and TG recipients
prior to MLN transfer (Table 1). We evaluated cell surface
expression of HLA-B27 to confirm the non-TG or TG status
of the donor and recipient rats.
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TCRαβ 49·4 ± 1·7 66·6 ± 1·9† 1·1 ± 0·1 1·9 ± 0·5
CD4 30·8 ± 1·8 51·8 ± 1·6† 2·3 ± 0·4 2·9 ± 0·1
CD45RClow/CD4+ 17·1 ± 1·8 37·3 ± 4·4† 1·8 ± 0·1 2·5 ± 0·3
CD8 17·8 ± 0·5 13·7 ± 0·6† 1·4 ± 0·1 1·3 ± 0·1
Surface Ig 48·9 ± 1·4 31·7 ± 2·2† 91·0 ± 0·5 93·5 ± 0·5
HLA-B27 0·7 ± 0·2 97·9 ± 0·4† 1·1 ± 0·3 98·4 ± 0·1
†P < 0·005 versus non-TG donor.
Fig. 1. Caecal inflammation in recipients of MLN cell transfers. Repre-
sentative sections of the caecum of rnu/rnu transgenic and nontrans-
genic recipient rats, eight weeks after transfer of MLN cells from rnu/+ 
transgenic or nontransgenic donors are shown at 10× magnification. 
Panels represent non-TG donor cells transferred into (a) non-TG or (c) 
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colitis is characterized by massive infiltration of granulocytes
and mononuclear cells of mucosa and submucosa, bowel
wall thickening, crypt abscesses, crypt hyperplasia, and gob-
let cell depletion. Rnu/rnu non-TG recipients that received
TG MLN cells remained disease-free, as shown in Fig. 1b.
Interestingly, adoptive transfer of rnu/+ non-TG MLN cells
into rnu/rnu TG recipients induced moderate colitis
(Fig. 1c). The disease that developed in rnu/rnu TG recipi-
ents of non-TG cells differs from the description of graft ver-
sus host disease (GVHD), which is characterized by a
constellation of severe inflammatory reactions in many tis-
sues including skin, liver, and small intestine but not the
large intestine [18]. We did not observe gross or clinical evi-
dence of dermal, hepatic, or small intestinal inflammation.
Moreover, in vitro proliferation of rnu/+ non-TG MLN cells
cultured with rnu/rnu TG MLN cells, which would be
expected if the non-TG cells induced GVHD, was minimal
(stimulation indices of 0·8–1·4 in three separate experi-
ments). Rnu/rnu non-TG recipients receiving non-TG MLN
cells did not show any signs of colitis (Fig. 1a). Histological
inflammatory scores (scale 0–4) confirmed the severe
inflammation in both caecum and colon in rnu/rnu TG
recipients receiving TG MLN cells, and moderate intestinal
inflammation in rnu/rnu TG recipients receiving non-TG
MLN cells (Fig. 2a,b). No disease was detected in rnu/rnu
non-TG rats receiving either non-TG or TG MLN cells
(P < 0·005 versus TG recipients) (Fig. 2a,b).
Flow cytometric analysis of MLN cells in rnu/rnu 
recipient rats after adoptive transfer
Evaluation of cell subpopulations was carried out on MLN
cells collected from all recipients, as shown in Table 2.
Eight weeks after MLN cell transfer, cells carrying the
HLA-B27 molecule comprised 40% of the total MLN cell
population in rnu/rnu TG recipients receiving non-TG
MLN cells. In contrast, no HLA-B27 positive cells were
detected after transfer of TG MLN cells into rnu/rnu non-
TG recipients, a consistent finding observed in three inde-
pendent experiments. Of interest, equivalent proportions
of CD4+ T cells were present in the rnu/rnu TG recipients
of either TG or non-TG donor MLN cells. MLN of rnu/rnu
non-TG recipients of TG MLN cells contained signifi-
cantly lower proportions of T cells and higher percentages
of B cells than did rnu/rnu non-TG recipients of non-TG
MLN cells.
Increased caecal MPO and IL-1β in rnu/rnu TG 
recipients
Inflammation in diseased rats was most severe in the cae-
cum. Therefore, we measured myeloperoxidase levels in
caecal tissue as a parameter of inflammation, and more spe-
cifically, granulocyte and macrophage infiltration. Rnu/rnu
TG recipients receiving TG MLN cells had higher caecal
Fig. 2. Caecal and colonic histological scores for recipients of MLN cell 
transfers. Intestinal tissue was collected from transgenic and nontrans-
genic rnu/rnu recipient rats, eight weeks after transfer of MLN cells from 
rnu/+ transgenic () or nontransgenic () donors. Blinded histology 
scores for (a) caecal and (b) colonic (average of proximal, transverse, 
and distal colon) tissue are shown. Values represent mean ± SEM, 
n = 5–8 rats per group. *P < 0·005 for histological scores of non-TG 




















































Table 2. Cell numbers and cell populations in mesenteric lymph nodes 


















52 ± 12 83 ± 21  60 ± 7 46 ± 9
TCRαβ 33·8 ± 3·7‡ 34·2 ± 2·6‡ 5·3 ± 1·2‡ 14·9 ± 1·2
CD4 30·8 ± 3·4‡ 29·6 ± 2·5‡ 4·1 ± 0·8‡ 13·2 ± 1·2
CD8 1·5 ± 0·2 4·2 ± 0·6 2·8 ± 0·3 2·2 ± 0·3
Surface Ig 56·4 ± 5·4‡ 60·0 ± 3·3‡ 89·5 ± 1·0† 77·7 ± 2·5
HLA-B27 92·5 ± 1·6‡ 40·6 ± 4·8‡ 0·4 ± 0·2 0·5 ± 0·1
Values represent mean ± SEM of percentages of the different lym-
phoid cell populations in MLN of recipients analysed eight weeks after
MLN cell transfer. †P < 0·01 versus non-TG donor cells transferred into
non-TG recipients, ‡P < 0·005 versus non-TG donor cells transferred
into non-TG recipients.
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MPO levels (albeit not statistically significant) and IL-1β lev-
els (P < 0·005) than rnu/rnu TG recipients of non-TG MLN
cells as shown in Fig. 3a,b. However, caecal MPO and IL-1β
levels were both significantly higher in TG recipients of non-
TG MLN cells than those found in caecal tissue from rnu/rnu
non-TG recipients receiving MLN cells from either type of
donor.
Cytokine profile in MLN cell cultures from rnu/rnu TG 
recipients after MLN cell transfer
Previously, we have shown that CD4+ T cells are critical for
IFN-γ production in HLA-B27 TG rats, whereas B cells are
required for IL-10 secretion [7]. In the present study, MLN
cells from recipients were isolated and stimulated in vitro
with caecal bacterial lysate. IFN-γ secretion in response to
stimulation by components of caecal bacteria present in the
lysate was significantly higher in rnu/rnu TG recipients com-
pared to rnu/rnu non-TG recipients (P < 0·005), as shown in
Fig. 4a. MLN cells collected from rnu/rnu TG recipients as
early as one week after transfer of TG donor cells produced
higher amounts of IFN-γ in response to caecal bacterial
lysate compared to stimulated MLN cells from rnu/rnu non-
TG recipients (Fig. 5). Interestingly, the amounts of IFN-γ
detectable in the supernatants of the recipient TG MLN cells
collected from rnu/rnu TG recipients at this early time point
after transfer were higher than the amounts produced by
caecal bacterial lysate-stimulated MLN cells from four
month old SPF rnu/+ TG rats with colitis (Fig. 5). IL-10 pro-
duced in response to caecal bacterial lysate was significantly
higher in cultures of rnu/rnu TG recipients of non-TG MLN
cells compared to rnu/rnu TG recipients of TG MLN cells
(P < 0·01, Fig. 4b).
Fig. 3. MPO and IL-1β in caecal tissue of cell transfer recipients. Trans-
genic and nontransgenic MLN cells from rnu/+ rats were transferred 
into rnu/rnu transgenic () or nontransgenic () recipients. After eight 
weeks, caecal tissue was collected, homogenized, and (a) MPO and (b) 
IL-1β were determined in duplicate supernatants. Values represent 
mean ± SEM, n = 5–8 rats per group. *P < 0·005 for caecal tissue from 






























































Fig. 4. Cytokine production by recipient MLN cells. MLN cells were 
collected from transgenic and nontransgenic recipient rats, eight weeks 
after transfer of MLN cells from rnu/+ transgenic () or nontransgenic 
() donors and cultured in the presence or absence of caecal bacterial 
lysate. After three days, supernatants were collected and (a) IFN-γ stim-
ulated by caecal bacterial lysate at 50 µg/ml and (b) IL-10 stimulated by 
caecal bacterial lysate at 10 µg/ml were measured in triplicate superna-
tants by ELISA. Values represent mean ± SEM, n = 5–8 rats per group. 
IFN-γ levels were significantly lower (*P < 0·005) and IL-10 levels were 
significantly higher (*P < 0·005) in supernatants of caecal bacterial 
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TG MLN donor cells proliferate and accumulate in TG 
but not in non-TG recipients
To obtain a better understanding of the kinetics of donor cell
survival and proliferation after transfer, we evaluated CFSE-
labelled TG donor cells after transfer into either rnu/rnu
non-TG or rnu/rnu TG recipients. CFSE-labelled dividing
cells can be easily monitored due to the incremental reduc-
tion in CFSE fluorescence intensity that occurs with each cell
division. On day two after transfer, two-fold more CFSE-
labelled cells were detectable in the MLN of TG recipients
compared to non-TG recipients (Fig. 6b versus 6f). Two pop-
ulations of TCRαβ-expressing cells are present (Fig. 6b,f).
One is CFSE positive, identifying donor cells, the other is
CFSE-negative. The CFSE-negative cells are either donor
cells that divided rapidly after transfer and thus lost detect-
able CFSE, or alternatively, these cells could represent the
minor population of TCRαβ-expressing cells that are
present in the MLN of rnu/rnu recipients (see Table 1). At
day seven, MLN of non-TG recipients no longer contain
CFSE-labelled cells (Fig. 6c,d) while MLN of TG recipients
contain CFSE-labelled TCRαβ-expressing cells that had
divided, as evidenced by their reduced fluorescence intensity
(Fig. 6g,h). It is interesting to note that the transferred cells
that do not express TCRαβ are not dividing (Fig. 6h, lower
right quadrant). We also evaluated spleen cells of the recip-
ients to determine if donor cells were more or less abundant
outside the MLN. More CFSE-labelled donor cells were con-
sistently seen in the MLN than in the spleen of either TG or
non-TG recipients (data not shown), excluding the possibil-
ity that donor MLN cells home to the spleen in non-TG rats.
Discussion
The results of the present study show that adoptive transfer
of MLN cells from either TG donor rats that develop colitis
or from disease-free non-TG donors into athymic TG recip-
ients induces inflammation in the caecum and colon. This
finding implicates accessory cells that express the HLA-B27
transgene as the activators of disease-inducing T cell
responses.
As demonstrated previously, T cells are required for
inflammation in HLA-B27 TG rats, since rnu/rnu TG rats
remain disease-free [8]. Moreover, CD4+ T cells have been
shown to mediate inflammatory responses in HLA-B27 TG
rats [8], and they produce large amounts of IFN-γ when
stimulated with components of commensal bacteria [7].
Peptides bound in the peptide binding grooves of MHC class
I molecules such as HLA-B27 are usually associated with
activation of CD8+, not CD4+ T cells. However, it has been
clearly shown that CD4, and not CD8 cells, are crucial for
disease-induction in HLA-B27 TG rats. CD4+ T cells were
much more efficient than CD8+ T cells in transferring disease
into nude HLA-B27 TG rats [8]. Additionally, the minor role
for CD8+ T cells in disease was shown by the lack of an effect
on colitis by either anti-CD8 treatment or CD8 depletion
in HLA-B27 TG rats [19]. In our study, CD8 cells did not
proliferate and the percentage of CD8+ cells detected by
flow cytometry after MLN cell transfer is low in all rnu/rnu
recipients.
CD4+ T cell subpopulations with regulatory functions
have been identified. In an elegant study, Powrie et al. [20]
showed that transfer of CD4+CD45RBhi T cells from normal
mice induced colitis in severe-combined immunodeficient
(SCID) mice. This inflammatory process could be prevented
by cotransfer of CD4+ cells that express low levels of CD45RB
from normal mice. This principle was shown originally in
athymic rats, where transfer of T cells that express high levels
of the CD45 isoform, designated CD45RC, mediated inflam-
mation in several different organ systems, whereas the sever-
ity of inflammation was greatly reduced by cotransfer of a
CD4+CD45RClow cell population [21]. Also B cells and
intraepithelial lymphocytes (IEL) have been suggested as
regulators of inflammation [22,23]. Taken together, analysis
of these different models of colitis indicates that disease
induction as well as regulation of inflammation are complex
processes that require interactions among a variety of differ-
ent cell types. In our study, we transferred a mixed cell pop-
ulation of non-TG or TG MLN cells into rnu/rnu athymic
HLA-B27 TG rats, resulting in moderate to severe colitis in
the recipients. Donor cells were unfractionated and con-
tained both CD45RClow CD4+ and CD45RChi CD4+ cells, as
well as B cells and CD8+ cells. We have shown previously that
MLN-derived rat B cells, but not T cells, produce IL-10 and
Fig. 5. IFN-γ production by caecal bacterial lysate stimulated MLN 
cells. MLN cells from rnu/+ TG rats were transferred into rnu/rnu non-
TG or rnu/rnu TG recipients. After seven days, recipient MLN were 
harvested, and cells were stimulated with caecal bacterial lysate at 50 µg/
ml or cultured without stimulation (medium). For comparison, MLN 
were also obtained from four month old SPF rnu/+ transgenic rats (not 
transplanted) and stimulated with caecal bacterial lysate or cultured 
with medium. Supernatants were collected after three days. IFN-γ was 
measured in triplicate supernatants by ELISA. Values represent mean ± 
SD of triplicate measurements from MLN cultures of individual ani-
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TGF-β in response to components of commensal bacteria
[7]. Our current findings indicate that CD45RClow CD4+cells
or B cells, from either TG or non-TG donors, failed to pre-
vent development of inflammation in rnu/rnu TG recipients.
Conversely, rnu/rnu non-TG recipients that do not express
HLA-B27 remain healthy, even after transfer of MLN cells
from TG donors with colitis.
IL-10 is an important immunoregulatory molecule [24].
For example, IL-10 is produced by regulatory T cells and is
crucial for the inhibition of colitis in the SCID mouse
CD4+CD45RBhi cell transfer model [25]. In another study,
IL-10 producing C3H/HeJBir CD4+ T regulatory cells, gen-
erated in vitro by sequential stimulation with caecal bacterial
antigens in the presence of IL-10, prevented onset of colitis in
Fig. 6. Equal numbers of CFSE labelled mesen-
teric lymph node cells from rnu/+ TG rats were 
transferred into rnu/rnu non-TG (a–d) or rnu/
rnu TG recipients (e–h). After two (a,b,e,f) and 
seven days (c,d,g,h), recipient mesenteric lymph 
node cells were collected and analysed by flow 
cytometry to enumerate CFSE-labelled cells 
(histograms) and cells that express TCRαβ (dot 
plots). Values represent percent positive cells in 
the labelled quadrants. Results shown from one 
transgenic and one nontransgenic recipient 
evaluated at each time point are representative of 
two rats of each type evaluated in independent 
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SCID recipients after cotransfer with colitis-inducing T cells
[26]. In HLA-B27 TG and non-TG rats, B cells are the main
source of IL-10 [7]. Although less IL-10 is secreted by MLN
cells from rnu/rnu TG recipients compared to those from
rnu/rnu non-TG recipients, MLN cells of rats from both
groups were able to produce IL-10. However, the capacity of
these cells to produce IL-10 was not sufficient to down-reg-
ulate caecal bacterial lysate-induced IFN-γ secretion by MLN
cells from rnu/rnu TG recipients. We have recently identified
hyporesponsiveness of TG MLN cells to IL-10 that might
also explain the inability of IL-10 to inhibit development of
colitis in TG recipients [27].
A major finding in our study is that accessory cells carry-
ing the HLA-B27 molecule determine the outcome of effec-
tor T cell responses. This is clearly demonstrated by the
finding that non-TG T cells are capable of inducing colitis
when transferred to rnu/rnu TG recipients. When the same
cells are transferred to rnu/rnu non-TG recipients, no disease
develops, indicating that the rnu/rnu host expressing trans-
genic HLA-B27 orchestrates T cell responses to commensal
bacteria. The importance of HLA-B27 in the activation of T
cell responses was further underlined by our observation
that addition of anti-HLA-B27 antibodies to cocultures of
TG CD4+ T cells plus caecal bacterial lysate- pulsed TG anti-
gen presenting cells reduced IFN-γ responses [28].
How can we explain that accessory cells determine disease
outcome, but that no disease occurs without T cells? There is
growing evidence that T cells are not acting in an indepen-
dent fashion, but are influenced by the innate immune sys-
tem [29]. Toll-like receptors (TLR) are crucial for innate
immune responses against microbial products [30]. These
responses can skew the acquired immune system, including
T cells, into regulatory or proinflammatory directions.
Therefore, dendritic cells and macrophages can regulate T
cell responses, not only by their direct antigen presentation
capacities, but also indirectly by the production of cytokines
that are induced after TLR-signalling [31]. Once T cells
become activated, the cytokines they produce subsequently
induce expression of a broad array of genes in antigen-pre-
senting accessory cells, such as IL-12/IL-23, IL-18 and
tumour necrosis factor-like 1A (TL1A), thus perpetuating
the immune response [32,33].
If CD4+ T cells, and not CD8+ T cells are required, how
does the MHC class I molecule HLA-B27 induce develop-
ment of inflammatory diseases? The molecular basis for the
development of spondyloarthrophies in human patients that
carry the HLA-B27 allele and for the occurrence of inflam-
matory conditions in HLA-B27 TG rats has not yet been
determined. However, recent reports implicate the unusual
biochemical properties of this MHC class I encoded mole-
cule in disease development. The B27 heavy chain can take
several different forms in addition to the classical het-
erodimer of the class I heavy chain noncovalently associated
with β-2 microglobulin that presents antigenic peptides to
CD8+ T cells [34]. One of the unusual forms results from
homodimerization of two B27 molecules. B27 homodimers
are capable of activating CD4+ T cells. An intriguing possi-
bility that would explain the development of HLA-B27-asso-
ciated disease was recently described by Kollnberger et al.
[35]. The results of their elegant study using tetramers of
B27 homodimers indicate that these molecules are able to
activate macrophages to produce TNF and nitric oxide,
which would then establish a receptive environment for the
development of inflammatory conditions. In separate stud-
ies, Turner et al. recently demonstrated the presence of mis-
folded HLA-B27 molecules accompanied by activation of
genes associated with endoplasmic reticulum stress in mac-
rophages from HLA-B27 TG rats [36,37]. Furthermore,
IFN-γ, one of the cytokines that is produced by HLA-B27
TG CD4 T cells [7], also activated many of the same ER
stress related genes in HLA-B27 TG rat macrophages but not
in macrophages derived from wild type rats [37]. HLA-B27
molecules alone are not sufficient to trigger inflammation,
since both germ-free HLA-B27 TG rats [3,6] and SPF rnu/
rnu TG rats [8] do not develop colitis. Taken together, these
observations indicate that the development of disease in
HLA-B27 TG rats requires the combination of misfolded
HLA-B27 in accessory cells, the presence of intestinal bacte-
ria, and CD4+ T cells that can be induced, as we show here,
to produce IFN-γ as early as one week after transfer into SPF
HLA-B27 rnu/rnu recipients. Although extra-intestinal
manifestations such as arthritis have been reported in HLA-
B27 transgenic rats, our specific pathogen free HLA-B27 TG
rats rarely develop arthritis. Therefore no conclusions can be
drawn from our study about the role of T cells or accessory
cells for the development of inflammation outside the intes-
tinal tract.
It is unclear what process determines the poor survival of
TG MLN cells in the rnu/rnu non-TG recipients. One possi-
bility is that, for this donor recipient combination, the donor
cells proliferate only minimally, and therefore form a minor
population relative to the endogenous cell population in the
recipients after eight weeks. This is supported by the results
of our cell transfer experiment using CFSE labelled cells.
Multiple cycles of proliferation were detected in TG recipi-
ents but not in non-TG recipients on day seven after MLN
cell transfer. Secondly, it is possible that a regulatory cytokine
environment predominates in non-TG recipients that
directly inhibits TG cell responses. Thirdly, TG donor cells
could be killed by NK cells of the non-TG host. Cells carry-
ing high copy numbers of HLA-B27 have reduced levels of
endogenous MHC class I molecules [2]. It is possible that
this feature makes TG donor cells prone to NK cell-mediated
lysis [38,39]. A fourth possibility is that the donor TG MLN
cells might undergo apoptosis following transfer into rnu/
rnu non-TG recipients, because their activation and subse-
quent survival depends on interactions with HLA-B27-
expressing accessory cells. Finally, other organs such as
spleen, liver, or lungs might trap donor cells, thereby pre-
venting these cells from reaching the MLN. Although we
F. Hoentjen et al.
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cannot rule out trapping of donor cells in nonlymphoid tis-
sues, we detected a higher percentage of CFSE-labelled
donor cells in MLN than in the spleen of TG recipients, sup-
porting the notion that MLN constitute an important site for
activation, proliferation, and survival of the transplanted
cells.
Caecal inflammation was more severe and caecal IL-1β
levels were higher in rnu/rnu TG rats after transfer of TG
MLN cells than non-TG MLN cells. A number of explana-
tions can be considered, including transfer of greater num-
bers of T cells (Table 1) as well as previously activated T cells
from TG compared to non-TG donors that are capable of
responding rapidly to stimulatory signals. Nonetheless, the
disease we have documented in rnu/rnu TG recipients of rnu/
+ non-TG MLN cells closely resembles the disease that devel-
ops in the HLA-B27 transgenic rat model of colitis.Several
published reports show reduced capacity of accessory cells,
such as dendritic cells, from HLA-B27 TG rats to activate
allogenic cells in vitro [40,41]. The results of our study, while
not directly addressing costimulatory activity, indicate that
cells of rnu/rnu TG recipients are potent stimulators of trans-
ferred syngeneic donor MLN cells in vivo. The role of acces-
sory cells in determining the nature of the immune response
has been extensively evaluated, and the results indicate that
antigen-presenting cells are crucial for both activation and
also for subsequent down-regulation of immune responses
[42]. The results of our in vivo transfer study indicate that
accessory cells in rnu/rnu TG recipients may lack the capacity
to inhibit the colitis-inducing abilities of CD4+ T cells from
donor rats that interact with HLA-B27 expressing cells.
In conclusion, we have shown that colitis develops in rnu/
rnu TG rats receiving TG or non-TG MLN cells. In contrast,
rnu/rnu non-TG rats remained disease-free after MLN cell
transfer. These observations suggest that the accessory cells
of the nude rats that carry HLA-B27 either orchestrate T cell
responses to luminal commensal bacteria or fail to ade-
quately regulate these responses. The results of our investi-
gation underscore the importance of HLA-B27 expressing
accessory cells in determining pathogenic host mucosal
immune responses to commensal bacteria.
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